Evidence map›Paper›PMID 38637500›Full record

ArticleNature communications2024

Monkeypox virus genomic accordion strategies.

Sara Monzón, Sarai Varona, Anabel Negredo, Santiago Vidal-Freire, Juan Angel Patiño-Galindo, Natalia Ferressini-Gerpe, Angel Zaballos, Eva Orviz, Oskar Ayerdi, Ana Muñoz-Gómez and 36 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 20 institutions in 2 countries.

Sara Monzón *Unidad de Bioinformática, Unidades Centrales Científico Técnicas, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Sarai Varona *Unidad de Bioinformática, Unidades Centrales Científico Técnicas, Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-2245-210X
Anabel Negredo *Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Santiago Vidal-Freire *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Juan Angel Patiño-GalindoDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Natalia Ferressini-GerpeDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0003-1210-3085
Angel ZaballosUnidad de Genómica, Unidades Centrales Científico Técnicas, Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-7555-5815
Eva OrvizCentro Sanitario Sandoval, Hospital Clínico San Carlos, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-2684-3431
Oskar AyerdiCentro Sanitario Sandoval, Hospital Clínico San Carlos, 28040, Madrid, Spain.
Ana Muñoz-GómezCentro Sanitario Sandoval, Hospital Clínico San Carlos, 28040, Madrid, Spain.
Alberto Delgado-IribarrenCentro Sanitario Sandoval, Hospital Clínico San Carlos, 28040, Madrid, Spain.
Vicente EstradaCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Cristina GarcíaCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Francisca MoleroCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Patricia Sánchez-MoraCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Montserrat TorresCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Ana VázquezCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Juan-Carlos GalánCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-8447-0960
Ignacio TorresServicio de Microbiología, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, 46010, Valencia, Spain.ORCID http://orcid.org/0000-0002-3604-190X
Manuel Causse Del RíoUnidad de Microbiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba, 14004, Córdoba, Spain.
Laura Merino-DiazUnidad Clínico de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, 41013, Sevilla, Spain.
Marcos LópezServicio de Microbiología y Parasitología, Hospital Universitario Puerta de Hierro Majadahonda, 28222, Madrid, Spain.
Alicia GalarServicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, 28007, Madrid, Spain.
Laura CardeñosoServicio de Microbiología, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, 28006, Madrid, Spain.
Almudena GutiérrezServicio de Microbiología y Parasitología Clínica, Hospital Universitario La Paz, 28046, Madrid, Spain.
Cristina LorasServicio de Microbiología, Hospital General y Universitario, 13005, Ciudad Real, Spain.
Isabel EscribanoServicio de Microbiología, Hospital General Universitario Dr. Balmis, 03010, Alicante, Spain.
Marta E Alvarez-ArgüellesServicio de Microbiología, Hospital Universitario Central de Asturias, 33006, Asturias, Spain.
Leticia Del RíoHospital Quironsalud Torrevieja, 03184, Alicante, Spain.
María SimónServicio de Microbiología, Hospital Central de la Defensa "Gómez Ulla", 28947, Madrid, Spain.
María Angeles MeléndezServicio de Microbiología y Parasitología, Hospital Universitario 12 de Octubre, 28041, Madrid, Spain.
Juan CamachoCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Laura HerreroCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Pilar JiménezUnidad de Genómica, Unidades Centrales Científico Técnicas, Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-2578-4855
María Luisa Navarro-RicoUnidad de Genómica, Unidades Centrales Científico Técnicas, Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0001-6963-6435
Isabel JadoCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-4871-9407
Elaina GiannettiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Jens H KuhnIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, 21702, USA.ORCID http://orcid.org/0000-0002-7800-6045
Mariano Sanchez-LockhartUnited States Army Research Institute for Infectious Disease, Fort Detrick, Frederick, MD, 21702, USA.
Nicholas Di PaolaUnited States Army Research Institute for Infectious Disease, Fort Detrick, Frederick, MD, 21702, USA.
Jeffrey R KugelmanUnited States Army Research Institute for Infectious Disease, Fort Detrick, Frederick, MD, 21702, USA.
Susana GuerraDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0002-6551-1827
Isabel CuestaUnidad de Bioinformática, Unidades Centrales Científico Técnicas, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Maripaz P Sánchez-SecoCentro Nacional de Microbiología, Instituto de Salud Carlos III, 28029, Madrid, Spain.
Gustavo PalaciosDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. gustavo.palacios@mssm.edu.ORCID http://orcid.org/0000-0001-5062-1938
Instituto de Salud Carlos III · ESIcahn School of Medicine at Mount Sinai · USHospital Clínico San Carlos · ESUnited States Army Medical Research Institute of Infectious Diseases · USHospital Central de la Defensa Gómez Ulla · ESHospital General Universitario de Alicante Doctor Balmis · ESHospital General Universitario de Ciudad Real · ESHospital General Universitario Gregorio Marañón · ESHospital Quirón Torrevieja · ESHospital Universitario 12 De Octubre · ESHospital Universitario Central de Asturias · ESHospital Universitario de La Princesa · ESHospital Universitario La Paz · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Virgen del Rocío · ESINCLIVA Health Research Institute · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESNational Institutes of Health · USUniversidad Autónoma de Madrid · ESUniversidad Nacional de Educación a Distancia · ES

Funding

NIAID NIH HHS HHSN272201800013C
6 · The paper itself

Abstract

The 2023 monkeypox (mpox) epidemic was caused by a subclade IIb descendant of a monkeypox virus (MPXV) lineage traced back to Nigeria in 1971. Person-to-person transmission appears higher than for clade I or subclade IIa MPXV, possibly caused by genomic changes in subclade IIb MPXV. Key genomic changes could occur in the genome's low-complexity regions (LCRs), which are challenging to sequence and are often dismissed as uninformative. Here, using a combination of highly sensitive techniques, we determine a high-quality MPXV genome sequence of a representative of the current epidemic with LCRs resolved at unprecedented accuracy. This reveals significant variation in short tandem repeats within LCRs. We demonstrate that LCR entropy in the MPXV genome is significantly higher than that of single-nucleotide polymorphisms (SNPs) and that LCRs are not randomly distributed. In silico analyses indicate that expression, translation, stability, or function of MPXV orthologous poxvirus genes (OPGs), including OPG153, OPG204, and OPG208, could be affected in a manner consistent with the established "genomic accordion" evolutionary strategies of orthopoxviruses. We posit that genomic studies focusing on phenotypic MPXV differences should consider LCR variability.

Indexed as

Mpox, MonkeypoxOrthopoxvirusPoxviridaeGenomicsHumansMonkeypox virus

Identifiers

PMID38637500
PMCPMC11026394
OpenAlexW4394924329

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.